Literature DB >> 25579797

FT-IR and FT-Raman spectroscopic signatures, vibrational assignments, NBO, NLO analysis and molecular docking study of 2-{[5-(adamantan-1-yl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N,N-dimethylethanamine.

Maha S Almutairi1, Amer M Alanazi1, Ebtehal S Al-Abdullah1, Ali A El-Emam1, Shilendra K Pathak2, Ruchi Srivastava2, Onkar Prasad3, Leena Sinha2.   

Abstract

FT-Raman and FT-IR spectra of the title compound 2-{[5-(adamantan-1-yl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N,N-dimethylethanamine were recorded and investigated. The DFT/B3LYP/6-311++G(d,p) method was used to compute the vibrational wavenumbers. A good coherence between experimental and theoretical wavenumbers shows the preciseness of the assignments. NLO properties like the dipole moment, polarizability, first static hyperpolarizability, molecular electrostatic potential surface and contour map have been calculated to get a better cognizance of the properties of the title molecule. Natural bond orbital analysis has been applied to estimate the stability of the molecule arising from charge delocalization. The molecular docking studies concede that title compound may exhibit HIV-1 Protease 1N49 inhibitory activity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FT-IR; FT-Raman; NBO; NLO

Mesh:

Substances:

Year:  2014        PMID: 25579797     DOI: 10.1016/j.saa.2014.12.064

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Design and in silico screening of aryl allyl mercaptan analogs as potential histone deacetylases (HDAC) inhibitors.

Authors:  Sugandha Singhal; Mallika Pathak; Paban K Agrawala; Himanshu Ojha
Journal:  Heliyon       Date:  2020-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.